XOMA Royalty Corporation (XOMA) Actualités

Initial Statement of Beneficial Ownership (3)

FORM 3          UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Initial Statement of Beneficial Ownership (3)

FORM 3          UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549...

Current Report Filing (8-k)

XOMA Corp DE false 0000791908 0000791908 2022-12-31 2022-12-31 0000791908 us-gaap:CommonStockMember 2022-12-31 2022-12-31 0000791908...

New Executive Leadership Team Appointed to Accelerate XOMA’s Differentiated Royalty Monetization Strategy

Owen Hughes appointed Executive Chairman of the Board of Directors and Brad Sitko joins as Chief Investment...

XOMA Declares Quarterly Preferred Stock Dividends

EMERYVILLE, Calif., Dec. 22, 2022 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the...

Current Report Filing (8-k)

XOMA Corp DE false 0000791908 0000791908 2022-11-21 2022-11-21 0000791908 us-gaap:CommonStockMember 2022-11-21 2022-11-21 0000791908...

XOMA Acquires Royalty and Milestone License to Ebopiprant, a Preterm Labor Asset, Being Developed by Organon

XOMA assumes the rights to ebopiprant from ObsEva, including the Organon License, Patent Estate, and Merck...

Confidential Treatment Order (ct Order)

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Current Report Filing (8-k)

XOMA Corp DE false 0000791908 0000791908 2022-11-03 2022-11-03 0000791908 us-gaap:CommonStockMember 2022-11-03 2022-11-03 0000791908...

XOMA Reports Third Quarter 2022 Financial Results and Highlights Recent Operational Events

Received first recurring royalty-style payment from Roche related to faricimab, its newly launched therapy for...

Current Report Filing (8-k)

XOMA Corp DE false 0000791908 0000791908 2022-10-25 2022-10-25 0000791908 us-gaap:CommonStockMember 2022-10-25 2022-10-25 0000791908...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

XOMA Declares Quarterly Preferred Stock Dividends

EMERYVILLE, Calif., Sept. 21, 2022 (GLOBE NEWSWIRE) --  XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the...